Market Place
Sourcing Support
FDA Staff Questions Confirmatory Trial Data For Intercept`s Liver Drug
12 Sep 2024 //
ENDPTS
COBALT Trial Findings Published In American Journal Of Gastroenterology
06 Sep 2024 //
GLOBENEWSWIRE
Alfasigma`s PBC treatment Ocaliva to face an FDA adcomm in September
09 Aug 2024 //
ENDPTS
Alfasigma S.p.A. Announces Expiration of Hart-Scott-Rodino Waiting Period
26 Oct 2023 //
BUSINESSWIRE
Alfasigma S.p.A. Tender Offer for Intercept Pharmaceuticals, Inc. Commences
11 Oct 2023 //
BUSINESSWIRE
Alfasigma to take over struggling Intercept
27 Sep 2023 //
FIERCE PHARMA
Alfasigma Acquires the Share Capital of SOFAR
20 Oct 2022 //
BIOSPACE
Alfasigma snares EU rights to blood clotting antibody
23 Jun 2021 //
ENDPTS
Alfasigma acquires European license for bentracimab from PhaseBio
22 Jun 2021 //
PRNEWSWIRE
Alfasigma buys back its European license for bentracimab from PhaseBio
22 Jun 2021 //
PRNEWSWIRE
Alfasigma USA, Inc. Engages Indegene, Inc. to Expand the Promotion of ZELNORM®
23 Jul 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.